A2i Therapeutics
Ness Ziona, HaMerkaz, Israel
About A2i Therapeutics
A2i Therapeutics develops novel therapeutic modulators of the protein that helps to control the immune response and neurological disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Dec 2020)
- Website: a2i-tx.com
- Phone: +972-08-955-3175
Industries & Categories
Biotechnology, Consulting, Product Research
Social Profiles
Canonical: https://fsome.com/organization/a2i-therapeutics-2522531 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.